BG

Bellevue Group Portfolio holdings

AUM $4.81B
1-Year Est. Return 29.28%
This Quarter Est. Return
1 Year Est. Return
+29.28%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$6.97B
AUM Growth
-$106M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
187
New
Increased
Reduced
Closed

Top Buys

1
+$25.6M
2
+$24.6M
3
+$12.1M
4
TNDM icon
Tandem Diabetes Care
TNDM
+$12M
5
CRL icon
Charles River Laboratories
CRL
+$6.28M

Top Sells

1
+$91.2M
2
+$42.4M
3
+$26.3M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$20.3M
5
AXSM icon
Axsome Therapeutics
AXSM
+$14.3M

Sector Composition

1 Healthcare 99.34%
2 Industrials 0.59%
3 Energy 0.02%
4 Communication Services 0.01%
5 Technology 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
76
$24.4M 0.35%
589,262
-6,118
77
$23.4M 0.34%
3,279,620
-259,435
78
$22.2M 0.32%
496,524
-320,617
79
$21.5M 0.31%
225,114
-4,039
80
$21.5M 0.31%
325,252
-664
81
$21.4M 0.31%
2,846,457
+175,044
82
$20.7M 0.3%
153,580
+2,380
83
$19.3M 0.28%
362,728
84
$18.7M 0.27%
301,850
-35,584
85
$18.5M 0.27%
84,612
-253
86
$17.5M 0.25%
515,030
-4,846
87
$17.2M 0.25%
319,548
-138,271
88
$17M 0.24%
666,419
-13,734
89
$16.4M 0.24%
88,333
-966
90
$16.2M 0.23%
4,494,458
91
$16.2M 0.23%
251,412
-19,413
92
$15.9M 0.23%
1,758,075
+1,768
93
$15.5M 0.22%
74,939
-60,301
94
$14.9M 0.21%
2,152,025
95
$12.2M 0.17%
260,835
-4,504
96
$12M 0.17%
17,389
-338
97
$10.7M 0.15%
5,898,583
+888,869
98
$10.2M 0.15%
45,196
-5,763
99
$9.89M 0.14%
390,286
-25,826
100
$9.86M 0.14%
503,007
2 3
4
5 6